Nord-Ostdeutsche Gesellschaft für Gynäkologische Onkologie e.V.

Publikationen

Die Noggo engagiert sich in vielfältiger Weise bei Studien und Umfragen.

Hier ein Überblick über aktuelle Veröffentlichungen:

Achimaş-Cadariu, P., Iancu, M., Kubelac, P., Pop, F., Braicu, I., Vlad, C., Oskay-Özcelik, G., and Sehouli, J. (2016). Expectations and perspectives of ovarian cancer patients about cancer management in Romania. The international NOGGO-ENGOT trial: EXPRESSION III. European Journal of Cancer Care.

Chekerov, R., Harter, P., Fuxius, S., Hanker, L.C., Woelber, L., Müller, L., Klare, P., Abenhardt, W., Nedkova, Y., Yalcinkaya, I., et al. (2017). Preference of elderly patients’ to oral or intravenous chemotherapy in heavily pre-treated recurrent ovarian cancer: final results of a prospective multicenter trial. Gynecol. Oncol. Res. Pract. 4, 6.

Harter, P., du Bois, A., Mahner, S., Pfisterer, J., Ortmann, O., Marth, C., Fink, D., Hilpert, F., Wagner, U., and Sehouli, J. (2016). Statement of the AGO Kommission Ovar, AGO Study Group, NOGGO, AGO Austria and AGO Switzerland Regarding the Use of Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Ovarian Cancer. Geburtshilfe Frauenheilkd 76, 147–149.

Karam, A., Ledermann, J.A., Kim, J.-W., Sehouli, J., Lu, K., Gourley, C., Katsumata, N., Burger, R.A., Nam, B.-H., Bacon, M., et al. (2017). Fifth Ovarian Cancer Consensus Conference of the Gynecologic Cancer InterGroup: first-line interventions. Ann. Oncol. Off. J. Eur. Soc. Med. Oncol. 28, 711–717.

Koensgen, D., Sehouli, J., Belau, A., Weiss, M., Stope, M.B., Grokopf, V., Eichbaum, M., Ledwon, P., Lichtenegger, W., Zygmunt, M., et al. (2017). Clinical Outcome of Neoadjuvant Radiochemotherapy in Locally Advanced Cervical Cancer: Results of an Open Prospective, Multicenter Phase 2 Study of the North-Eastern German Society of Gynecological Oncology. Int. J. Gynecol. Cancer Off. J. Int. Gynecol. Cancer Soc. 27, 500–506.

Möbus, V., von Minckwitz, G., Jackisch, C., Lück, H.-J., Schneeweiss, A., Tesch, H., Elling, D., Harbeck, N., Conrad, B., Fehm, T., et al. (2017). German Adjuvant Intergroup Node-positive Study (GAIN): a phase III trial comparing two dose-dense regimens (iddEPC versus ddEC-PwX) in high-risk early breast cancer patients. Ann. Oncol. Off. J. Eur. Soc. Med. Oncol. 28, 1803–1810.

Muallem, M.Z., Dimitrova, D., Pietzner, K., Richter, R., Feldheiser, A., Scharfe, I., Schmeil, I., Hösl, T.M., Mustea, A., Wimberger, P., et al. (2016). Implementation of Enhanced Recovery After Surgery (ERAS) Pathways in Gynecologic Oncology. A NOGGO-AGO* survey of 144 Gynecological Departments in Germany. Anticancer Res. 36, 4227–4232.

Sehouli, J., Tomè, O., Dimitrova, D., Camara, O., Runnebaum, I.B., Tessen, H.W., Rautenberg, B., Chekerov, R., Muallem, M.Z., Lux, M.P., et al. (2016). A phase III, open label, randomized multicenter controlled trial of oral versus intravenous treosulfan in heavily pretreated recurrent ovarian cancer: a study of the North-Eastern German Society of Gynecological Oncology (NOGGO). Journal of Cancer Research and Clinical Oncology.

Sehouli, J., Tomè, O., Dimitrova, D., Camara, O., Runnebaum, I.B., Tessen, H.W., Rautenberg, B., Chekerov, R., Muallem, M.Z., Lux, M.P., et al. (2017). A phase III, open label, randomized multicenter controlled trial of oral versus intravenous treosulfan in heavily pretreated recurrent ovarian cancer: a study of the North-Eastern German Society of Gynecological Oncology (NOGGO). J. Cancer Res. Clin. Oncol. 143, 541–550.

Sehouli, J., Chekerov, R., Reinthaller, A., Richter, R., Gonzalez-Martin, A., Harter, P., Woopen, H., Petru, E., Hanker, L.C., Keil, E., et al. (2016). Topotecan plus carboplatin versus standard therapy with paclitaxel plus carboplatin (PC) or gemcitabine plus carboplatin (GC) or pegylated liposomal doxorubicin plus carboplatin (PLDC): a randomized phase III trial of the NOGGO-AGO-Study Group-AGO Austria and GEICO-ENGOT-GCIG intergroup study (HECTOR). Annals of Oncology mdw418.

Sehouli, J.,  Woopen, H., Pavel, M., Richter, R., Lauterbach, L.-K., Taube, E., Darb-Esfahani, S., Fotopoulou, C., and Pietzner, K. (2016). Neuroendocrine Neoplasms of the Ovary: A Retrospective Study of the North Eastern German Society of Gynecologic Oncology (NOGGO). Anticancer Res. 36, 1003–1009.

Wilson, M.K., Pujade-Lauraine, E., Aoki, D., Mirza, M.R., Lorusso, D., Oza, A.M., du Bois, A., Vergote, I., Reuss, A., Bacon, M., et al. (2017). Fifth Ovarian Cancer Consensus Conference of the Gynecologic Cancer InterGroup: recurrent disease. Ann. Oncol. Off. J. Eur. Soc. Med. Oncol. 28, 727–732.

Woopen, H., Inci, G., Richter, R., Chekerov, R., Ismaeel, F., and Sehouli, J. (2016). Elderly ovarian cancer patients: An individual participant data meta-analysis of the North-Eastern German Society of Gynecological Oncology (NOGGO). European Journal of Cancer 60, 101–106.

Woopen, H., Richter, R., Ismaeel, F., Chekerov, R., Roots, I., Siepmann, T., and Sehouli, J. (2016). The influence of polypharmacy on grade III/IV toxicity, prior discontinuation of chemotherapy and overall survival in ovarian cancer. Gynecologic Oncology 140, 554–558.